1Glimelius B,Hoffman K,Haglund U,et al. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol,1994,5:189-190.
2Murad AM,Santiago FF,Petroianu A,et al. Modified therapy with 5-fluorouracil,doxorubicin,and methotrexate in advanced gastric cancer. Cancer,1993,72:37-41.
3Pyrhonen S,Kuitunen T,Nyandoto P,et al. Randomized comparison of fluorouracil,epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer,1995,71:587-591.
4Ajani JA. Standard chemotherapy for gastric carcinoma:is it a myth? J Clin Oncol,2000,18:4001-4003.
5Vanhoefer U,Rougier P,Wilke H,et al. Final results of a randomized phase Ⅲ trial of sequential high-dose methotrexate,fluorouracil,and doxorubicin versus etoposide,leucovorin,and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer:A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Group. J Clin Oncol,2000,18:2648-2657.
6Ohtsu A,Shimada Y,Shirao K,et al. Randomized phase Ⅲ trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable,advanced gastric cancer:The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol,2003,21:54-59.
7Kim NK,Park YS,Heo DS,et al. A phase Ⅲ randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil,doxorubicin,and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer,1993,71:3813-3818.
8Yamao T. Rationale for neoadjuvant chemotherapy for advanced gastric cancer. In: Nakajima T,Yamaguchi T. eds. Multimodality therapy for gastric cancer. Tokyo:Springer-Verlag,1999. 115-121.
10Takiguchi N,Nunomura M,Koda K,et al. Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion. Oncol Rep,2003,10:433-438.
